| Apr 1 |
2 “Strong Buy” Stocks Insiders Are Snapping Up
|
| Mar 30 |
Epizyme Comeback Is Likely, Price Makes It A Buy
|
| Mar 26 |
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
|
| Mar 25 |
Epizyme (EPZM) Down 22.9% Since Last Earnings Report: Can It Rebound?
|
| Mar 15 |
Epizyme (EPZM) Presents At The Next EPIsode: Rewriting Oncology Treatment with Epigenetics - Slideshow
|
| Mar 15 |
Epizyme (EPZM) Presents At Barclays Global Healthcare Conference - Slideshow
|
| Mar 2 |
Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call
|
| Feb 28 |
The Epizyme, Inc. (NASDAQ:EPZM) Analysts Have Been Trimming Their Sales Forecasts
|
| Feb 25 |
Epizyme downgraded at Morgan Stanley citing pandemic impact
|
| Feb 25 |
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2021
|
| Feb 24 |
Epizyme to Host Strategic Vision Call on March 2, 2021
|
| Feb 24 |
Epizyme Inc (EPZM) Q4 2020 Earnings Call Transcript
|
| Feb 23 |
Epizyme's (EPZM) CEO Rob Bazemore on Q4 2020 Results - Earnings Call Transcript
|
| Feb 23 |
Return On Capital Employed Overview: Epizyme
|
| Feb 23 |
Epizyme, Inc. 2020 Q4 - Results - Earnings Call Presentation
|
| Feb 23 |
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
|
| Feb 23 |
Epizyme: Q4 Earnings Insights
|
| Feb 23 |
Epizyme Q4 top-line down 95%, Tazverik revenues reach $4.5M
|
| Feb 23 |
Epizyme EPS misses by $0.06, beats on revenue
|
| Feb 23 |
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
|
| Feb 23 |
Earnings Scheduled For February 23, 2021
|
| Feb 22 |
Epizyme Q4 2020 Earnings Preview
|
| Feb 20 |
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
|
| Feb 16 |
Epizyme Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Participation in Upcoming Investor Conferences
|
| Feb 14 |
Reassessing Epizyme
|
